In a recent publica tion of m ajor importance, entitled "Th e Leprosy Problem ' of the World,"! the World H calth Organization h as presented fi gures for registered 
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for some ]80 countri es and rcgions in Afri ca, th e Ame ri cas, As ia, E urope and Oceania.
. Such a compilation, in spite of inev itable current defi ciencies in accuracy and co mpleteness of coverage, has been grea tl y needed. The limitations are set forth cl early and frankl y by th e authors, and it may be anticipated th at the report itself will lead to improved reporting . in regions finding th emselves not accurately represented , and at th e same tim e stimul ate health offi cers in all countries w here leprosy is endemic to reduce th e present gap between registered cases, and th e all too vague number of "estim ated" cases.
The au th ors' procedure for es timating cases is itself illuminating in this res pect. Basic fi gures used were those of th e WHO Leprosy Ad visory Team (LA T ) which conducted random sa mplin g surveys in Africa (Northern N igeri a, North , Central and South Ca meroon ) and As ia ( the Philippines, Kh on Kaen, Tha il and, and Myingyan and Shwebo, Burma ). These showed th a t in regions w ith fairl y good case-findin g programs, new cases amountin g to 75 per cent of the currentl y registered cases could be found. It was reasonable to believe th at in regions with poor case-findin g programs th e proportion of detectable new cases would be mu ch hi gher. For this reason arbitrary allowances we re made for casereporting in different types of region, with addition of 75, 150 or 300 per cent respectively of th e number of registered cases as es timations of the currentl y undetected cases in countries with satisfactory, fair or poor case-findin g programs. In a few counh'ies in Europe where leprosy is still end emic it was felt that only 25 per cent needed to be added. In some countries, on the other hand, virtuall y no b as ic da ta were avail able; in th ese cases th e only es timations th at could be made were based on the prevalence rates reported in neighboring countries .
Rates of prevalence obviously are based on population fi gures, whi ch are themselves ra ther gross es timates, rath er th an accurate census compil ations in many countries. With all of these defects and pitfalls it is easy to see th at statements on prevalence and rates could. be m ade only with caution and clea r indica tion of reservat ions necessa ry. Th e present compil at ion is a brave step in opening up a tremendous task.
The d ata brought out in th e study of prevalence in th e five contin ental areas are set forth in a length y ta bl e givin g th e date of fi gures used (generall y 1962-1965) , the es timated population , th e source of inform ation employed ( usu all y health deparhnent or WHO Hegional Offi ce re ports), and th e number of leprosy patients, fi gures for whi ch were broken down into registered , trea ted and es tim ated cases. Four summ arizing tab les foll ow, of w hi ch one is reprinted below. F in all y a hi ghl y infonmltive map of th e world is included , with shading and cross-hatchin g for th e va rying calcul ated prevalence rates for leprosy in different p arts of th e world.
The authors' own concise summ ary can b e used to present th e res ults of th eir analysis most sliccinctl y:
"There is a t present a lack of accurate data on th e prevalence of le prosy in th e different countries of th e world, primarily because case-finding has not reached th e desired level in many of them. The authors have attempted to provide more realistic fi gures, usin g inform ation obtained from several sources and va rious criteri a for calculating es tim ated prevalence rates. In all there are 2,831,755 registered patients and 10,786,000 es tim ated cases; th e la tter fi gure may wen be an under-es tim ate. The number of trea ted pa tients is about 1,928,000, some 68 per cent of the registered cases and 18 per cent of th e estimated . About 2,097 million people live in areas with prevalence rates of 0.5 per 1,000 or higher ; in these areas nearl y one million new cases of leprosy can be expected within th e next fi ve years. The es tim ated number of disabled p atients is 3,872,000, of whom 1,961 ,-000 are in disability grades 2-5 (excluding anes thesia to pain ). The data represent an attempt, made with many reserva tions, to give an indica tion of the magnitude of th e leprosy problem throu ghout the world."
It is worth notin g that in a number of countries, w ith populations totalling something over 150 million persons, th e prevalence rate is recorded as hi gher th an 10 per thousand. Amon g some five million people in areas with the mos t seriou s prob-3.5,2
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lem th e preva lence rate is more than 50 per thousand or on e person in twenty. The authors' T able 2 ( our Table 1 below F
gives an overall view of registered , estimated and treated cases in the fi ve continental areas. It will b e noted th a t Asia and Africa account for more than 90 pe r cent of all cases, and that the pe rcentage of treated registe red cases in As ia is rela ti vely high.
A number of items ca ll for special comment. Ideally some breakdown into type~' of leprosy ( leprom atou s, tuberculoid, borderlin e, indetermin a te, or comparable classifi cation ) would b e desirable. This would indeed b e too much to expect in data col· lected from th e sources used , which varied grea tl y in reporting procedures. An indica tion of the infectiousness or noninfectiousness of the cases recorded would b e equally desirable, and likewise, for th e p resent, 'vyou ld b e an una tta in able goa l. Actually th e authors touch on th e problem a t issue in notin g th e rela tively hi gh leproma tous rate in Asia, as compared wi th th e rate in Africa, whil e pointing out tha t high prevalence rates are ma intained in h yperendemic areas where tuberculoid leprosy "This is awhms ' Tahl c 2. Th t: rdt: rcll ccs rdc l to a llth ors' Table I. constitutes as much as 90 per cent of the total cases. As th e a uth ors sugges t, such fi gures presumably mean th at a proportion of the more resistant forms are open and infectious p art of the time.
In this connection m ay b e noted the authors record of the W HO estima tes of the number of n ew leprosy cases to b e expected in the next five years in counh'ies with a prevalence rate of 0.5 p er 1,000 population or higher. This estim ate is approximately a million cases, distributed as follows: Africa, 312,000; Americas 26,000; Asia, 650,000; E urope, 3,000; and Oceania, 4,000.
In the absence of figures on infectiousn ess and typ e of disease the au thors a re able to supply d ata with regard to recognizable disabilities du e to leprosy, graded accordin g to a system previously publish ed. a These fi gures give a picture of the severity of th e problem in different regions as reBected in the social as well as medical aspects of the disease.
The reader's attention w ill inevitably b e drawn to certain extraordinarily high fi g. "No information abou t 12 countri es (see Table I ). "No informat ion abo lll 26 countries (see Table I ) . ' Informa ti on abo ut 16 countri cs onl y (sec Table I ). "Informa ti on abo ut 26 countri es onl y (see T ablc I). ":-10 information about Mongoli a. ' Information abo u t 22 cOlin tries onl y (see Table I ) . lU"CS, especially those for cen tral and equatorial Africa, parts of south eas t As ia, pa rticul arl y Burma, French Gui ana in South America, and a few p laces in th e south Pacific. The significance of high recorded prevalence is relatively cl ear; a faithful record of an actual fact is generall y represented, b ased on careful epid emi ologic stud y. The significance of low rates, on the other hand, is often doubtful. A low fi gure could mean a genuinely low prevalence; it could · mean, however, simpl y a failure of the health services to find cases th at actuall y exist. Indifference in rep ortin g cases of chronic disease commonl y res ults in low recorded rates. Experience in such areas regul arly shows th at when intensified surveys are introduced recorded prevalence rates rise. In this connection the authors cite the case of French \Vest Africa. In 1938 the number of cases of leprosy was 'o:lstim ated as 30,000. Twenty-fi ve years later the number of cases in the region !previously fonnin g French \ Ves t Africa was {ecorded as 550,384, i.e., nearl y 20 times the previous fi gure. Some of the rise was presum ably due to increase in population, but it may b e assumed th at improved case findin g was responsible for most of it. The case of mainl and China certainly calls for special note. Bechelli and Martin ez do not accord specific attention to it, simply recordin g an es tim ate of 2,279,000 cases fo r a populati on of about two-thirds of a billion persons. No fi gures for registered or treated cases are recorded . The case of India is in marked contrast, with an es timate of 2,500,000 cases, broken down in regis tered, estim ated, and trea ted categories, in nearly half a b illion popula tion. The recorded sources of inform ation are different, and it would seem, in the light of the free communications concerned, that the fi gures for India are the more reliable. Certainly if we are to have a comprehensive picture of lep rosy as a world problem, tru stwo rth y fig ures for Ch ina are necessary. T he world cannot afford to do no more th an gucss a t the prevalence of leprosy in a single segment believed to represent a third of the world's popul ation.
Finall y, before long, a "case" of leprosy will have to be more accurately defin ed th an is at present possible. D oubtl ess the problem will be q uite as diffi cult as the vexed one of classifica tion. A read y analogy is app arent in the oth er world-wide mycobacterial disease, tubercul os is. At one time it was enough to delineate progress in terms of recorded dea ths from th e disease. When the mortality rates declined to low levels, case rates were substituted in the records and in the knowled ge of the informed public. But tubercul os is case-rates are dependent on arbitrary definitions of a "case," which vary from region to region, w ith no rigidl y sharp lines all the way from a mere positive tuberculin reaction to a patient with ulcera tive pulmonary disease. Yet b asic records are now good enou gh so th at it is possible to calculate case rates on any one of several arbitraril y chosen definition s of a "case," and fi gures are valuable when such rates are calculated serially over a peri od of years.
It would seem that comparable progress in leprosy reporting should be possible. In each of the q uinq uennial international congresses of leprology much attention is devoted to the cl assifica tion of leprosy. In the forth coming 1968 congress it would appear wise to set up standards for more definitive case reporting than are presently in effect, as well as to stimulate in every poss ible way th e recording and discovery of cases of leprosy throughout th e world. 4 -E. R. LONe 
